Table 4.
Low density lipoprotein cholesterol (LDL-C) contents in blood samples.
| LDL | 0D | 6D | 18D | 24D | 30D | 42D |
|---|---|---|---|---|---|---|
| A | 22.33 ± 7.896 | 15.63 ± 4.228 | 28.45 ± 8.157 | 23.03 ± 3.350 | 16.94 ± 3.410 | 16.28 ± 3.567 |
| B | 26.23 ± 7.143 | 68.03 ± 24.60*** | 67.22 ± 13.45*** | 83.22 ± 21.49*** | 88.98 ± 32.26*** | 98.80 ± 35.21*** |
| C | 23.24 ± 6.831 | 51.57 ± 14.85*** | 70.48 ± 17.22*** | 89.36 ± 44.32*** | 114.1 ± 62.90*** | 92.35 ± 52.31*** |
| D | 18.56 ± 5.616 | 57.10 ± 17.34*** | 49.71 ± 14.07∗∗∗, ## | 69.78 ± 20.54*** | 88.17 ± 19.97*** | 80.05 ± 29.15*** |
| E | 21.98 ± 3.974 | 47.85 ± 17.38∗∗∗, # | 51.16 ± 9.723∗∗∗, ## | 60.05 ± 21.35∗∗∗, # | 98.18 ± 38.69*** | 74.29 ± 29.43*** |
| F | 19.76 ± 2.608 | 42.43 ± 16.61∗∗∗, ## | 50.66 ± 12.67∗∗∗, ##,† | 76.53 ± 43.37*** | 87.61 ± 48.40*** | 73.00 ± 32.86*** |
| G | 26.94 ± 6.340†† | 36.67 ± 13.89∗∗∗, ###,†† | 47.81 ± 14.72∗∗∗, ## | 109.1 ± 44.91∗∗∗,† | 97.41 ± 40.59*** | 70.91 ± 63.17* |
| H | 23.69 ± 3.758 | 57.83 ± 17.86*** | 42.15 ± 21.41## | 125.0 ± 41.28∗∗∗, ##,††† | 98.78 ± 49.10*** | 81.14 ± 37.11*** |
| I | 19.82 ± 8.215 | 41.70 ± 13.06∗∗∗, ## | 58.39 ± 17.87*** | 125.3 ± 48.83∗∗∗, # | 83.46 ± 39.26*** | 61.13 ± 39.13∗∗, # |
| J | 18.98 ± 13.67 | 30.55 ± 11.18∗∗∗, ### | 45.82 ± 8.996∗∗∗, ### | 88.52 ± 19.35*** | 113.9 ± 53.11*** | 64.00 ± 35.28*** |
Low density lipoprotein cholesterol (LDL-C) contents were assayed by assay kits as described in the text.
Values were mean ± SD (n = 12) and expressed in mg/dL.
The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001.
The # indicates a significant difference compared with model group, # P < 0.05, ## P < 0.01, ### P < 0.001.
The † indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D, H compared to E), † P < 0.05, †† P < 0.01, ††† P < 0.001.